Beating both EPS and sales estimates, especially by such a large margin in sales, typically generates positive investor sentiment and can lead to short-term stock price appreciation. The significant outperformance in sales suggests aTyr Pharma is gaining traction, potentially leading to upward revisions in future earnings estimates and increased investor interest.